ZS PHARMA INC COMS TK (DE)
ZSPH
ZSPH was delisted on the 16th of December, 2015.
8 hedge funds and large institutions have $18M invested in ZS PHARMA INC COMS TK (DE) in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSA
Wall Street Associates
Lajolla,
California
|
+$4.52M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.16M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.16M |
| 4 |
VM
VHCP Management
New York
|
+$2.83M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.61M |
Top Sellers
ZSPH Hedge Fund Activity: Q2 2014 in Review
8 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in ZS PHARMA INC COMS TK (DE) (ZSPH) for Q2 2014, worth a combined $18M.
Buyers outnumbered sellers: 8 funds opened new ZSPH positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wall Street Associates, opening a new position worth an estimated $4.52M.
- 8 institutional investors held ZS PHARMA INC COMS TK (DE) (ZSPH) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $18M of ZS PHARMA INC COMS TK (DE) stock for Q2 2014.
- 8 funds opened new ZS PHARMA INC COMS TK (DE) positions in Q2 2014 and 0 closed out, a net change of +8 holders.
- The largest ZS PHARMA INC COMS TK (DE) buyer in Q2 2014 was Wall Street Associates, an estimated $4.52M added.
Based on aggregated 13F filings for Q2 2014.